BBIO · Categories · Downgrades

BBIO - Analyst downgrades

BridgeBio Pharma Inc. (BBIO) analyst downgrades - real-time wire coverage filtered to Downgrades only.

Recent Downgrades for BBIO

• 27d
  BridgeBio Pharma downgraded by Raymond James

  Raymond James downgraded BridgeBio Pharma from Outperform to Mkt Perform
• 1070d
  BridgeBio Pharma downgraded by Jefferies with a new price target

  Jefferies downgraded BridgeBio Pharma from Buy to Hold and set a new price target of $33.00 from $24.00 previously

Other BBIO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings